GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | September 04, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
6XC9 | 6XC9 | Immune receptor complex | |
6XC7 | 6XC7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022 | |
6XC4 | 6XC4 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 | |
6XC3 | 6XC3 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022 | |
6XC2 | 6XC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 | |
6X9V | 6X9V | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
6X9U | 6X9U | HIV-1 Envelope Glycoprotein BG505 SOSIP.664, expressed in HEK293S cells and partially deglycosylated by endoglycosidase H, in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
6X9T | 6X9T | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293S cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
6X9S | 6X9S | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in stable CHO cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
6X9R | 6X9R | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 expressed in HEK293F cells in complex with RM20A3 Fab | HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, RM20A3 Fab Heavy Chain, RM20A3 Fab Light Chain |
6X98 | 6X98 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11B fragment antigen binding variable domain | |
6X97 | 6X97 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 11A fragment antigen binding variable domain | |
6X96 | 6X96 | Cryo-EM model of HIV-1 Env BG505 SOSIP.664 in complex with rabbit monoclonal antibody 10A fragment antigen binding variable domain | |
6X5S | 6X5S | Human Alpha-1,6-fucosyltransferase (FUT8) bound to GDP and A3'-Asn | |
6X5R | 6X5R | Human Alpha-1,6-fucosyltransferase (FUT8) bound to GDP and A2-Asn | |
6X5B | 6X5B | Symmetric model of CD4- and 17-bound B41 HIV-1 Env SOSIP in complex with small molecule GO52 | Envelope glycoprotein gp160, 17b Fab light chain, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4, 17b Fab heavy chain |
6X4T | 6X4T | Crystal structure of ICOS-L in complex with Prezalumab and VNAR domain | |
6X4G | 6X4G | Crystal structure of ICOS in complex with ICOS-L and an anti ICOS-L VNAR domain | |
6X40 | 6X40 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin | |
6X40 | 6X40 | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus picrotoxin | |
6X3Z | 6X3Z | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA | |
6X3Z | 6X3Z | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA | |
6X3X | 6X3X | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam | |
6X3X | 6X3X | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus diazepam | |
6X3W | 6X3W | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital | |
6X3W | 6X3W | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus phenobarbital | |
6X3V | 6X3V | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate | |
6X3V | 6X3V | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus etomidate | |
6X3U | 6X3U | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil | |
6X3U | 6X3U | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus flumazenil | |
6X3T | 6X3T | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol | |
6X3T | 6X3T | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with GABA plus propofol | |
6X3S | 6X3S | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | Gamma-aminobutyric acid receptor subunits beta-2, alpha-1, gamma-2, Kappa Fab Light Chain, IgG2b Fab Heavy Chain |
6X3S | 6X3S | Human GABAA receptor alpha1-beta2-gamma2 subtype in complex with bicuculline methbromide | Gamma-aminobutyric acid receptor subunits beta-2, alpha-1, gamma-2, Kappa Fab Light Chain, IgG2b Fab Heavy Chain |
6X1T | 6X1T | Structure of pHis Fab (SC50-3) in complex with pHis mimetic peptide | |
6WZT | 6WZT | CryoEM structure of influenza hemagglutinin A/Victoria/361/2011 in complex with cyno antibody 3B10 | Hemagglutinin, Cyno antibody light chain, Cyno antibody heavy chain |
6WYT | 6WYT | Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1B | |
6WYR | 6WYR | Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1A | |
6WXL | 6WXL | Cryo-EM structure of the VRC315 clinical trial, vaccine-elicited, human antibody 1D12 in complex with an H7 SH13 HA trimer | |
6WW7 | 6WW7 | Structure of the human ER membrane protein complex in a lipid nanodisc | ER membrane protein complex subunit 1, ER membrane protein complex subunit 2, ER membrane protein complex subunit 3, ER Membrane Protein Complex Subunit 4, Membrane magnesium transporter 1, ER membrane protein complex subunit 6, ER membrane protein complex subunit 7, ER membrane protein complex subunit 8, ER membrane protein complex subunit 10 |
6WVZ | 6WVZ | Crystal structure of anti-MET Fab arm of amivantamab in complex with human MET | |
6WTH | 6WTH | Full-length human ENaC ECD | Amiloride-sensitive sodium channel subunit alpha, Amiloride-sensitive sodium channel subunit beta, Amiloride-sensitive sodium channel subunit gamma, 7B1 Fab, 10D4 Fab |
6WRX | 6WRX | Crystal structure of computationally designed protein 2DS25.1 in complex with the human Transferrin receptor ectodomain | |
6WRW | 6WRW | Crystal structure of computationally designed protein 2DS25.5 in complex with the human Transferrin receptor ectodomain | |
6WRV | 6WRV | Crystal structure of computationally designed protein 3DS18 in complex with the human Transferrin receptor ectodomain | |
6WPT | 6WPT | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
6WPT | 6WPT | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment (open state) | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
6WPS | 6WPS | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
6WPS | 6WPS | Structure of the SARS-CoV-2 spike glycoprotein in complex with the S309 neutralizing antibody Fab fragment | SARS-CoV-2 spike glycoprotein, S309 neutralizing antibody heavy chain, S309 neutralizing antibody light chain |
6WP8 | 6WP8 | Proton-pumping mutant of Mastigocladopsis repens rhodopsin chloride pump |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024